Abstract:Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominant skeletal dysplasia characterized by short stature, abnormal epiphyses, and flattened vertebral bodies. Secondary prevention of SEDC can be achieved by prenatal diagnosis. Reports of antenatally-diagnosed SEDC fetuses have been very rare and molecular prenatal diagnosis even rarer. We previously reported a familial G504S mutation in the type II collagen (COL2A1) gene resulting in SEDC. In this study, molecular prenatal diagnosis was performed to 2 couples in this family with pregnancies at risk for SEDC.Amniotic fluid was sampled by amniocentesis under ultrasound guidance at 19+3 and 18+6 weeks' gestation, respectively. Karyotype and molecular genetic analysis were performed on cultured amniotic fluid cells. Maternal cell contamination was excluded by short tandem repeat (STR) analysis. Direct DNA sequencing and DHPLC were conducted to detect the potential mutation in exon 23 of COL2A1 gene. Both women underwent serial sonograms because they insisted that the molecular diagnosis should be confirmed by another method, although they had been informed that mutation analysis is predictive of the disease.Karyotype of both fetuses was normal and molecular genetic analysis revealed that fetus 1 carried a G504S mutation in exon 23, while fetus 2 was normal. In case 1, femur length of the fetus was markedly below the 5th centile at 23 weeks' gestation, which confirms the accuracy of molecular diagnosis. A medical termination was carried out at 27+5 weeks' gestation and a male fetus with a relatively large head and short limbs was delivered. The fetal radiograph demonstrated a number of features, including generalised platyspondyly, absent ossification of the vertebral bodies in the cervical region and significant shortening of the long bones. The diagnosis of SEDC was thus confirmed clinically. Ultrasound monitoring of fetus 2 showed that its femur length was normal for gestational age at repeated scans, which was consistent with the molecular diagnosis.Molecular analysis allows early and accurate prenatal diagnosis for SEDC once mutation is known in a family. However, considering the poor genotype/phenotype correlation in many cases of SEDC, the combination of ultrasound as well as molecular genetic approach might be needed.

A Novel Mutation in COL2A1 Leading to Spondyloepiphyseal Dysplasia Congenita in a Three-Generation Family

[Identification of a Novel Mutation of COL2A1 Gene in a Chinese Family Affected with Spondyloepiphyseal Dysplasia Congenita].

Identification of three novel mutations in the COL2A1 gene in four unrelated Chinese families with spondyloepiphyseal dysplasia congenita.

A novel <i>COL2A1</i> mutation causing spondyloepiphyseal dysplasia congenita in a Chinese family

A Novel De Novo Mutation in COL2A1 Leading to Spondyloepiphyseal Dysplasia Congenita in a Chinese Family.

A novel COL2A1 mutation causing spondyloepiphyseal dysplasia congenita in a Chinese family

A Novel Mutation c.3392G>T of COL2A1 Causes Spondyloepiphyseal Dysplasia Congenital by Affecting Pre-mRNA Splicing

Novel and Recurrent COL2A1 Mutations in Chinese Patients with Spondyloepiphyseal Dysplasia.

A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid.

Gene Location And Mutation Detection In A Large Chinese Family With Sedc And Molecular Prenatal Diagnosis Of Sedc

Novel Carbohydrate Sulfotransferase 3 Mutation Causing Spondyloepiphyseal Dysplasia with Congenital Joint Dislocations in a Chinese Family

Ultrastructural study on spondyloepiphyseal dysplasia congenita cartilage resulted from COL2A1 gene mutation

Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia.

Clinical Diagnosis of X-Linked Spondyloepiphyseal Dysplasia Tarda and a Novel Missense Mutation in the Sedlin Gene (SEDL).

Identification of One Novel Mutation in the C-propeptide of COL2A1 in a Chinese Family with Spondyloperipheral Dysplasia

Molecular prenatal diagnosis in 2 pregnancies at risk for spondyloepiphyseal dysplasia congenita.

[Mutational Analysis in a Family with X-linked Spondyloepiphyseal Dysplasia Tarda].

Rapid Molecular Prenatal Diagnosis of Spondyloepiphyseal Dysplasia Congenita by PCR-SSP Assay

Exome sequencing revealed<i> USP9X</i> and<i> COL2A1</i> mutations in a large family with multiple epiphyseal dysplasia

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

A Novel Missense Variant in the CHST3 Underlies Spondyloepiphyseal Dysplasia with Congenital Joint Dislocations